Townhall + Tv

BioInvent CEO Highlights Major Milestone and Future Goals | Dr. Martin Welschof, CEO , BioInvent International AB. 00:10:00

Dr. Martin Welschof is the CEO of BioInvent International AB, a Swedish company specializing in the development of first-in-class immuno-modulatory antibodies for cancer treatment. He has a robust scientific and executive background in biotechnology. Before joining BioInvent, Dr. Welschof was the CEO of Opsona Therapeutics and a co-founder and managing director of Affitech A/S in Oslo and Copenhagen. Additionally, he served as the Director of Technology at Axaron Bioscience.

BioInvent CEO Highlights Major Milestone and Future Goals | Dr. Martin Welschof, CEO , BioInvent International AB. 00:10:00

Recent Videos

Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.

Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.

Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.

Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.

SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.

Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.

BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.

Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.

Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.

Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.

Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.

Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.

Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.

Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.

Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.

Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

Mastering Market Movements: A Day in the Life of a Long/Short Equity Analyst | Sarah Johnson - Equity Analyst, Point72

Staying Positive Through Entrepreneurial Challenges | Glenn Sanford, CEO, eXp World Holdings Inc.

Supporting Veterans: Financial Guidance & Mentorship

"Liquidity Challenges in Emerging Markets: Insights from Standard Life Investments"

Recover Funds from Coin Aate Scams with MFG Inc

Assessing International Markets: Evaluating Valuations, Interest Rates, and Investment Strategies | Euan Munro , CEO , Newton Investment Management .

Defining Our Core Values: Integrity, Trust, and Communication

"Key Considerations: What Capital Partners Seek in Independent Sponsors - Insights from the 2021 Independent Sponsor Conference"

Horizon’s Legacy Navigator: Streamlining Acquisitions and Successions

Ricoh Inc. President and CEO Yoshinori "Jake" Yamashita discusses the company's initiatives and strategies.

Manas Resources Explores Growth Opportunities at One-to-One Conference in Cape Town

Trading of Caverion Oyj shares (trading symbol: CAV1V) commenced on the NASDAQ OMX Helsinki Main Market on July 1, 2013.